Catalyst Wire Dossier Catalyst Wire Dossier

Azetukalner

· Xenon Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Azetukalner, covering 2025-10-22 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) [Phase 3]

See pricing